
Substance Abuse Treatment Market by Substance Abuse Type (Alcohol Addiction, Cocaine, Marijuana), Product (Behavioral Treatment, Drugs), Treatment Option, Distribution Channel - Global Forecast 2024-2030
Description
Substance Abuse Treatment Market by Substance Abuse Type (Alcohol Addiction, Cocaine, Marijuana), Product (Behavioral Treatment, Drugs), Treatment Option, Distribution Channel - Global Forecast 2024-2030
The Substance Abuse Treatment Market size was estimated at USD 7.04 billion in 2023 and expected to reach USD 7.72 billion in 2024, at a CAGR 10.01% to reach USD 13.74 billion by 2030.
Global Substance Abuse Treatment Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Substance Abuse Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Substance Abuse Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Substance Abuse Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare Limited, Alkermes PLC, Amphastar Pharmaceuticals, Inc., BioCorRx, Inc., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Elite Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Indivior, LFB Group, Mallinckrodt LLC, Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Reckitt Benckiser Group PLC, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris Inc..
Market Segmentation & Coverage
This research report categorizes the Substance Abuse Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
Substance Abuse Type
Alcohol Addiction
Cocaine
Marijuana
Nicotine Addiction
Product
Behavioral Treatment
Drugs
Acamprosate
Buprenorphine
Bupropion
Disulfiram
Methadone
Naltrexone
Varenicline
Treatment Option
Group Counseling
In-patient Treatment
Individualized Drug Counseling
Long-Term Residential Treatment
Outpatient Treatment Programs
Short-Term Residential Treatment
Distribution Channel
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Substance Abuse Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Substance Abuse Treatment Market?
3. What are the technology trends and regulatory frameworks in the Substance Abuse Treatment Market?
4. What is the market share of the leading vendors in the Substance Abuse Treatment Market?
5. Which modes and strategic moves are suitable for entering the Substance Abuse Treatment Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Substance Abuse Treatment Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing cases of tobacco addiction across the globe
- 5.1.1.2. Increasing patient awareness and higher treatment seeking rate
- 5.1.1.3. Favorable efforts from the governments to curb the use of these substances
- 5.1.2. Restraints
- 5.1.2.1. Relatively high cost of the treatment and poor treatment compliance
- 5.1.3. Opportunities
- 5.1.3.1. Emerging number of treatment centers with partnerships with private recovery facilities
- 5.1.3.2. Growing introduction of new products and therapy coupled with better reimbursement options
- 5.1.4. Challenges
- 5.1.4.1. Increasing cases of discontinuation of behavioral therapies and patients opt for outpatient care
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Substance Abuse Treatment Market, by Substance Abuse Type
- 6.1. Introduction
- 6.2. Alcohol Addiction
- 6.3. Cocaine
- 6.4. Marijuana
- 6.5. Nicotine Addiction
- 7. Substance Abuse Treatment Market, by Product
- 7.1. Introduction
- 7.2. Behavioral Treatment
- 7.3. Drugs
- 7.4.1. Acamprosate
- 7.4.2. Buprenorphine
- 7.4.3. Bupropion
- 7.4.4. Disulfiram
- 7.4.5. Methadone
- 7.4.6. Naltrexone
- 7.4.7. Varenicline
- 8. Substance Abuse Treatment Market, by Treatment Option
- 8.1. Introduction
- 8.2. Group Counseling
- 8.3. In-patient Treatment
- 8.4. Individualized Drug Counseling
- 8.5. Long-Term Residential Treatment
- 8.6. Outpatient Treatment Programs
- 8.7. Short-Term Residential Treatment
- 9. Substance Abuse Treatment Market, by Distribution Channel
- 9.1. Introduction
- 9.2. Hospital Pharmacies
- 9.3. Retail Pharmacies & Drug Stores
- 10. Americas Substance Abuse Treatment Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Substance Abuse Treatment Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Substance Abuse Treatment Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. AbbVie Inc.
- 14.1.2. Accord Healthcare Limited
- 14.1.3. Alkermes PLC
- 14.1.4. Amphastar Pharmaceuticals, Inc.
- 14.1.5. BioCorRx, Inc.
- 14.1.6. Cipla Limited
- 14.1.7. Dr. Reddy’s Laboratories Ltd.
- 14.1.8. Elite Pharmaceuticals, Inc.
- 14.1.9. GlaxoSmithKline PLC
- 14.1.10. Glenmark Pharmaceuticals Limited
- 14.1.11. Indivior
- 14.1.12. LFB Group
- 14.1.13. Mallinckrodt LLC
- 14.1.14. Novartis International AG
- 14.1.15. Pfizer Inc.
- 14.1.16. Purdue Pharma L.P.
- 14.1.17. Reckitt Benckiser Group PLC
- 14.1.18. Sanofi S.A.
- 14.1.19. Teva Pharmaceutical Industries Ltd.
- 14.1.20. Viatris Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. SUBSTANCE ABUSE TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. SUBSTANCE ABUSE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. SUBSTANCE ABUSE TREATMENT MARKET DYNAMICS
- FIGURE 7. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2023 VS 2030 (%)
- FIGURE 8. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY SUBSTANCE ABUSE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
- FIGURE 12. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 14. SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SUBSTANCE ABUSE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. SUBSTANCE ABUSE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. SUBSTANCE ABUSE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.